Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Total Debt (2016 - 2025)

Historic Total Debt for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $609.5 million.

  • Amphastar Pharmaceuticals' Total Debt rose 214.63% to $609.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $609.5 million, marking a year-over-year increase of 214.63%. This contributed to the annual value of $601.9 million for FY2024, which is 200.83% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Total Debt of $609.5 million as of Q3 2025, which was up 214.63% from $608.7 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Total Debt's 5-year high stood at $638.6 million during Q3 2023, with a 5-year trough of $38.5 million in Q2 2021.
  • In the last 5 years, Amphastar Pharmaceuticals' Total Debt had a median value of $501.2 million in 2023 and averaged $344.7 million.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Total Debt plummeted by 1747.44% in 2021, and later skyrocketed by 74374.5% in 2023.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Total Debt stood at $77.0 million in 2021, then fell by 1.42% to $75.9 million in 2022, then skyrocketed by 677.51% to $590.0 million in 2023, then rose by 2.01% to $601.9 million in 2024, then increased by 1.27% to $609.5 million in 2025.
  • Its Total Debt was $609.5 million in Q3 2025, compared to $608.7 million in Q2 2025 and $604.1 million in Q1 2025.